info@example.com

+1 66589 14556

PSA After Prostate Cancer Treatment

PSA After Prostate Cancer Treatment

📖 5 min read Written and medically reviewed by Dr. Alhad Naragude, MBBS, MS, DrNB Urology Last updated: September 6, 2026

PSA is the most useful blood marker for follow-up after prostate-cancer treatment, but the expected pattern depends on what treatment you had. After radical prostatectomy, almost all PSA-producing prostate tissue has been removed, so PSA should fall to an undetectable or very low level within weeks. After radiation therapy, the prostate remains in the body and benign prostate cells continue to make PSA, so the value usually falls gradually and does not need to reach zero. A rising PSA can be the earliest sign of recurrence, often long before symptoms appear. The definition and urgency of recurrence are therefore different after surgery and radiation.

PSA after radical prostatectomy

PSA is generally checked several weeks after surgery and then at regular intervals. A persistently detectable PSA may indicate residual prostate tissue or cancer, while a later rise after an initially undetectable level suggests biochemical recurrence. Different guidelines and laboratories use slightly different thresholds, and ultrasensitive PSA can detect very small values before formal recurrence criteria are met.

PSA after radiation therapy

PSA falls slowly because the prostate is still present. It may take 18 months or longer to reach its lowest level, called the nadir. A temporary “PSA bounce” can occur after external-beam radiation or brachytherapy and does not automatically mean recurrence.

The commonly used Phoenix definition of biochemical recurrence after radiation is a PSA rise of 2 ng/mL or more above the post-treatment nadir. Clinical decisions may sometimes begin before this threshold if the pattern and imaging are strongly concerning.

PSA after treatment at a glance

Treatment Expected PSA pattern Typical concern
Radical prostatectomy Falls rapidly to undetectable/very low Persistent detectable PSA or confirmed rise after an undetectable level.
Radiation therapy Gradual decline; benign prostate remains Sustained rise; Phoenix definition is nadir + 2 ng/mL.
ADT Often falls substantially as testosterone is suppressed Rising PSA despite castrate testosterone may indicate castration-resistant progression.
Focal therapy PSA falls but prostate tissue remains No single universally accepted PSA-only definition; MRI, biopsy and PSA pattern are combined.

What is PSA doubling time?

PSA doubling time estimates how quickly the PSA is rising. A short doubling time generally indicates more active disease and can influence imaging and treatment decisions. It should be calculated from multiple reliable values rather than two tests taken too close together.

When is PSMA PET useful?

PSMA PET/CT can detect recurrent disease at lower PSA levels than conventional imaging in many patients. It may show whether recurrence appears confined to the prostate bed, pelvic lymph nodes or distant sites, helping guide salvage radiation or systemic treatment. A negative scan at a very low PSA does not prove there is no microscopic recurrence.

What if PSA rises after surgery?

Early salvage radiation to the prostate bed — sometimes including pelvic nodes and/or ADT depending on risk — can be curative in selected men. Outcomes are generally better when salvage treatment is delivered at a low PSA rather than waiting for a large rise. The decision uses pathology, PSA kinetics, time from surgery and imaging.

What if PSA rises after radiation?

The first step is to determine whether recurrence is local, regional or metastatic. Local salvage options in carefully selected men include salvage prostatectomy, cryotherapy, high-intensity focused ultrasound or re-irradiation techniques at experienced centres. Systemic therapy is used when disease is not suitable for local salvage.

Persistent PSA and recurrent PSA are not identical problems

After radical prostatectomy, some men never reach an undetectable PSA. This is called PSA persistence and can suggest residual local, nodal or distant disease. In others, PSA becomes undetectable and rises later, which is biochemical recurrence. The timing and pattern differ, and that difference can influence staging imaging and salvage treatment.

After radiation there is no equivalent expectation of immediate undetectability because benign prostate tissue remains. The nadir, time to nadir, PSA bounce and subsequent sustained rise are interpreted together.

When to seek urgent medical care

A detectable or rising PSA after treatment usually needs prompt specialist review but not emergency care by itself. Seek urgent assessment for new severe back pain with leg weakness/numbness, loss of bladder or bowel control, inability to pass urine, heavy haematuria, chest pain or severe breathlessness. These symptoms should be acted on regardless of the latest PSA value.

Consultation checklist

  • All PSA values after treatment with dates.
  • Final prostatectomy pathology or radiation summary.
  • Whether ADT was given and when the last dose was administered.
  • Current testosterone if on or recently off ADT.
  • PSMA PET/CT or other imaging if already done.
  • Any new urinary, bone or constitutional symptoms.

FAQs

What PSA should I have after prostatectomy?

It should generally become undetectable or very low. The exact laboratory threshold and timing matter, so individual values should be interpreted with the treating team.

Does PSA need to be zero after radiation?

No. Benign prostate tissue remains and continues to produce PSA.

What is PSA bounce?

A temporary PSA rise followed by a fall, often seen after radiation or brachytherapy. It can mimic recurrence but is not cancer progression by itself.

Can PSMA PET be negative even if PSA is rising?

Yes. Very small-volume disease can remain below imaging detection, especially at low PSA values.

Should salvage radiation wait until PSA becomes high?

Usually not. For appropriate post-prostatectomy recurrence, salvage radiation is generally more effective when given at lower PSA levels.

Related reading

References

Note: This information is for educational purposes only and is not a substitute for medical advice. Please consult your doctor for any symptoms.